More than 70 years have passed since the prophylactic treatment of rabies with dried attenuated vaccine was first reported by L. Pasteur1.
But the treatment of rabies to-day still remaines on the same therapeutic principles of giving active immunity by repeated injections of an emulsion prepared of the nervetissue of animals infected with fixed virus before the street virus invades into and proliferates in the central nerve-tissue of the injured. Thus, clinicians are still troubled with the postvaccinal paralysis. Moreover, as it was detected by Nitsch2 and Dodero3, the vaccination is useless or even harmful as it shortens the incubation period when the injury is severe.
On the other hand, in nearly all instances, the locality infected and the time of infection are quite evident indicating the availability of immune serum. Following the report by Babes and Lepp4 in 1889 on a dog survived the subdural injection of street virus after it had received 6 successive daily injections of immune serum obtained from a dog immunized with rabies vaccine, numerous reports have been published on rabies immune serum treatment some stating that it is highly benefitlal5 6 7 8 9 12 13 14 15 16 17 and the others useless10 11, But most of those studies were not satisfactory on the points that the number of the animals used was too small, the neutralizing antibody titer of immune serum used was not precisely determined, the method of infection and the dosage used were not adequate etc. While, A. Hoyet, et al.14 in 1935 statistically proved the effectiveness of immune serum against the experimental infection attempted on mice with fixed virus.
In the year 1945, K. Habel18, being based on the experimental findings of animal protection tests (guinea pigs, mice and monkeys) by the use of rabbit immune serum and street virus or fixed virus as challenge virus, stated that the protective effect was observed on the animals received immune serum and practically no difference was observed in the prophylactic effect between the vaccination started immediately after and that started 3 to 6 days after serum injection, and he concluded that the first application of immune serum and then to start vaccination upon positive diagnosis of the pigs within 24 to 72 hours after infection with the street virus recovered from the salivatry gland of a rabid dog, could lower the number of fatal cases, and that the combined application of this immune serum and Semple's vaccine showed no antagonism nor synergism of the antigen and antibody, and further, he recommended the use of this combined therapy presenting 2 evidences of successful treatment both injured by positively rabid animals. In our country, the incidence rate of rabies has remarkably increased since the end of the last world war and a considerable number of postvaccinal paralysis cases have occurred.
Thus, efforts have been excised on the improvements of the vaccine as well as on the prophylactic use of immune serum.
As the result of animal experiment, in which rabbit immune serum highly immunized with fixed virus was used, the application of immune serum within 6 hours after infection was statistically20 proved to protect mice infected with fixed virus. The experiment in which street virus was used as infecting virus also confirmed the above finding21.
Reported in the following are the details of similar experiments carried out by using immune serum obtained from the horses highly immunized with the fixed virus.
Further, the prophylactic effect of the treatment with horse hyperimmune serum alone was compared with that of the combined treatment of the same immune serum and the vaccine inactiveted by ultra-violet irradiation.
Reports were also made on the findings of clinical experiments on several cases injured by genuine rabid animals.
MATERIALS AND METHODS

Immunization:
Fixed virus MDH strain was inoculated intracerebrally into mice or guinea pigs and the brains of the moribund animals having developed rabies were harvested aseptically and emulsified in Waring blendor to obtain a physiological saline suspension in a concentration of 10 to 20%. After centrifugation at 1,500 rpm for 10 minutes, the supernatant fluid obtained was placed under the influence of ultraviolet irradiation following the method previously described25.
Upon confirmation of the complete inactivation, the emulsion was used for immunization.
Animal for immunization : The animal used for immunization was a mare 10 years old weighing approximately 400 kg. Method o f immunization : Ultra-violet inactivated vaccine of MDH strain in a form of 10% emulsion in a dose of 0.5 ml was inoculated intracutaneously into the cervix repeating for 6 times.
After an interval of 7 days, the same emulsion was inoculated for additional 7 times each in a dose of 1.0 ml. Seven days after, the subcutaneous inoculation of living MDH strain virus was started.
The animal was bled once per month for the examination of the rise in the blood antibody titer. The method used for the titration was the usual in vitro neutralization test with 10 fold serial dilutions of the virus.
The immunization was suspended for 4 months in the middle of the course.
But by the end of 10 months after starting immunization, the neutralizing antibody titer became as high as 1 ml of the serum to neutralize 1,000,000LD50 of CVS strain.
The animal was given another injection of living virus MDH strain.
A partial bleeding of 5 to 8 liters was done after additional 7 to 10 days, a total of 27 liters were bled during a course of 18 months after starting immunization without developing any unusual finding. For the titration of the neutralizing antibody of immune serum, mice weighing 9 to 10 gm were used, while mice weighing approximately 15 gm were used the potency test of vaccine. Vaccine used : The vaccine used by itself or in combination with immune serum was prepared from the brain tissue of the guinea pigs intracerebrally infected with rabies virus MDH strain.
The animals were bled to death when on the critical stage after developing paralysis of the limbs. The brains harvested were placed in glass tubes, which were subsequently flame sealed and preserved in dry ice for use. In some occasions, the vaccine was prepared immediately after harvest. The brains were ground in Waring blendor with phosphate buffered saline solution at pH 7.6 to obtain a 10% emulsion. This emulsion was used as it was or after centrifugation at 1,500 rpm and inactivat ing the supernatant by continuous flow irradiation system reported by HabelSockrider25 et al. As Habel's test hitherto used is not of complete satisfaction for knowing the potency of highly potent vaccine, a method to use several dilutions of vaccine for the immunization of mice weighing approximately 15 gm and to challenge them with 32 to 100 LD50 of the virus of CVS strain which had been preserved in refrigerator and then to calculate LD50 and point by Reed-Meunch's method was used in the present experiment.
Habel's test, however, was also carried out occasionally.
Later, the potency test of rabies vaccine which will be enforced from September 1954 in the United States26 was found to resemble very much to the one mentioned above. Therefore, this U.S. potency test was also taken into consideration for knowing the potency of the vaccine used in the present experiment.
EXPERIMENTAL FINDINGS
Animal protection experiment with immune serum and ultraviolet irradiated vaccine against the challenge of street virus.
We have already proved that there is a statistically significant difference in the morbidity rate and in the period of incubation between the mice treated with the immune serum within 6 hours and the animals in the control group after infection either with fixed virus or with street virus.
In the present experiment, ref ering to Koprowski, hamsters weighing 60 to 80 gm were used.
Findings are shown in Table 6 .
The infecting virus was prepared from the brain tissue of the mouse infected with the brain emulsion of a man who had developed rabies and died of it. The virulence of the virus inoculated in a dose of 0.03 ml intracerebrally into the brain of white mice weighing 9 to 19 gm and that inoculated in a dose of 0.1 ml intramuscularly into the femoral muscule of hamsters weighing 60 to 80 mg, is shown in the upper part of Table 6 . Hamsters, 40 in number, received the intramuscular inoculation of the emulsion in a dilution of 10-2 each in a dose of 0.1 ml (5 LD 50 ) into the interior femoral muscle.
Groups each consisted of five hamsters selected at random received the injection of 0.2 ml of the purified immune serum at the same site where virus inoculation had been made 3 hours, 24 hours, 48 hours, 72 hours or 96 hours after virus inoculation. A group of 5 hamsters received the injection of immune serum 3 hours after virus inoculation in the same manner and at the same time received the intraperitoneal injections of ultraviolet inactiveted vaccine in a concentration of 5% repeating for 6 times once per every other day. Another group of 5 hamsters received only the injections of the same vaccine in the same manner.
Moreover, another group of 5 hamsters was kept aside to control the experiment without any treatment.
The findings of observation continued for 95 days are shown in Table 6 . As it is easily known from the table, the majority of animals in the control group developed rabies after an incubation period of approximately 12 days, while the survival rate of all the groups treated either with immune serum, vaccine or by their combination was 77% at 95 days after virus inoculation.
This fact indicated a prophylactic effect of immune serum against rabies. Shown in Table 7 are the findings of the experiment in which a large dose of immune serum Lot I was used.
The virus used for infection was the brain emulsion of hamsters developed rabies following the injection with the brain emulsion of a mouse infected with street virus 182 strain.
Its virulence was 5.17 LD50 in mice (9 to 10 gm) inoculated intracerebrally and 3.52 LD50 in hamsters (60 to 80 gm) inoculated intramuscularly. Twenty hamsters received an intramuscular inoculation with a 10-2 dilution of the above mentioned emulsion each in a dose of 0.2 ml into the femoral muscle of the right side. Purified immune serum in a dose of 0.2 ml was injected intramuscularly into the same site immediately, 6 hours and 24 hours after virus inoculation, while 5 hamsters were set aside without treatment to control the experiment. The morbidity rate of rabies was low in each of the groups treated with immune serum when compared with that of the control group. This might probably due to an extremely large dose of immune serum injected.
Moreover, the incubation period of those animals which had developed rabies was longer than 50 days except one, which was 18 days among the group received immune serum 24 hours after infection, indicating that the immune serum treatment was evidently beneficial. On the other hand, however, in spite of prolongation in the incubation period, 7 out of the 15 hamsters which had been treated with immune serum developed rabies. This fact indicates that even with highly potent immune serum, if the treatment given is only once, rabies may develop later in spite of prolongation in the incubation period.
Koprowski reported that Syrian hamsters weighing 70 to 80 gm develop rabies mostly 14 to 30 days after infection with street virus. In the present experiments, the animals in the control groups developed rabies 11 to 22 days after infection. Since the prophylactic effect of immune serum only was not satisfactory, attempts were made to employ immune serum and vaccine combined treatment .
A total of 108 guinea pigs weighing 350 to 400 gm received an intramuscular inoculation of a 10% brain emulsion of the mouse infected with street virus No. 84 strain, each in a dose of 0.2 ml into the right femoral muscle. The LD 50 of inoculated virus was 3.86 in the guinea pigs received intramuscular inoculation and, 4.83 in the mice weighing 9 to 10 gm received intracerebral inoculation. They were divided into 6 groups each consisted of 18 guinea pigs. The animals in the Group 1 received, 24 hours after infection, an injection of 0.5 ml of horse immune serum (Lot V, neutralization titer against fixed virus 150,000,000 LD50 per ml in mice intracerebral inoculation test) into right and left femoral muscle alternatively every other day for 6 times. The animals in Group 2 received a single injection of the same immune serum in a dose of 0.5 ml intramuscularly which was followed by 6 times of intraperitoneal vaccination with ultraviolet inactivated vaccine (Lot U.V. 161, 0.25 %) each in a dose of 1.0 ml. Those in Group 3 received a single injection of immune serum which was followed by 6 times of intracutaneous inoculation with the same vaccine each in a dose of 0.1 ml. The animals in Groups 4 and 5 received only vaccine injection exactly in the same manner as those done in Groups 2 and 3. Shown in Table 8 are the findings of the comparison made with the control group. The period of observation was 100 days. Generally speaking, the preliminary treatment with immune serum applied within 24 hours of infection was found to be quite efficient in preventing the development of rabies regardless of the application of booster vaccination.
As it is known from the survival rates, when infected with the virus of such a large dose as used in the present experiment, the vaccination was found to be even harmful rather than prophylactic.
At least , it seems that the prophylactic effect of immune serum is not lessened by simultaneous inoculation of the vaccine and the groups received vaccine-serum combined treatment presenting a survival rate practically the same as that of the serum treatment group in which the amount of the immune serum used was 6 times as much as that of the combined treatment.
Moreover, the animals (Groups 2 and 3) injected intramuscularly with 0.5 ml of the immune serum showed no appreciable difference in the survival rate in spite of the 10 times difference in the amount of vaccine used. This fact could not be the result of excellent; antigenicity of the vaccine used. In view of the above mentioned findings, the immediate application of immune serum, when received a bite or a scratch by an animal suspected of rabies, is considered to be quite rational as it has been advocated by K. Habel'5 and H. Koprowski19.
As a prophylactic treatment of rabies, we too recommend the immediate use of immune serum upon injury without waiting for the establishment of laboratorial diagnosis of the suspected animal, starting vaccination only when the diagnosis proves to be positive.
As for the amount of immune serum to be given, nothing definite can be said at present . Of course, it is not the problem of quantity but is the neutralizing antibody titer of the immune serum.
Clinical application of immune serum.
Effectiveness of immune serum in preventing the onset of rabies being confirmed on animal experiments as stated in the above, investigations were made on its clinical application.
Following points should be taken into consideration when evaluating the statistics of rabies in human subject27: 1. Whether or not the animal which gave the injury had been genuine rabies.
2. Whether or not the injury was severe enough to penetrate the skin .
3. When several persons received injury by the same animal at the same time, the order of the injury received, because there might be a considerable difference in the amount of virus present in the saliva of the animal .
4. Whether or not there was a chance in which the fractured nerve tissue at the injury was exposed to the contact with the virus present in the saliva of the rabid animal. This decision may be extremely difficult, out it is quite evident that this has been the cause of the difference in the morbidity rates of rabies between the persons injured on their faces, neck etc where the peripheral nerves are thickly distributed and those injured on extremities.
However, A person should be considered to have been exposed under a great dange of developing rabies when received an injury which caused bleeding by an animal whose saliva was proved positive in the virus isolation regardless of the site injured . The findings of antibody titer in the blood and spinal fluid determined by serial dilutions of virus are shown in Tables 10 and 11 . A considerably high neutralizing antibody titer was observed immediately after starting serum injection, however, a remarkable decrease was noted as early as 8 days after completion of the serum treatment. By the end of 30 days after starting serum injection, which was January 12th, as stated above, vaccine treatment was started. Practically no neutralizing antibody was proved present in the blood collected on February 13th which was 20 days after completion of the vaccination .
Findings shown in Table 11 are those of the similar tests made on the spinal fluid. A rise in the neutralizing antibody was observed immediately after immune serum injection. The remarkable decrease observed on December 26th, which was 9 days after completion of the spinal injection of immune serum, was exactly in the same manner as that observed with the blood neutralizing antibody titer. 
DISCUSSION
The findings of our experiments on the immune serum prophylactic treatment by using hamsters and guinea pigs infected with street virus, as it has been proved by our forerunners, that the application of immune serum alone prevents the onset of rabies, provided the serum treatment started within a certain definite period of time after infection.
Moreover, in the present experiment, approximately half the total number of the hamsters weighing 70 to 80 gm and the guinea pigs weighing 400 to 450 gm both infected intramuscularly with an amount of the virus 15 to 1,000 times as much of their respective LD50 dose were protected from developing rabies.
This finding indicates the possibility that, in the case of human subjects in whom the incubation period is much longer than that of those animals, the application of immune serum at a time much later than the above mentioned would still successfully prevent the onset of rabies. The application of immune serum, in our experiment, as late as 48 hours and 72 hours after infection proved its effectivepess the survival period of all the animals in 48 hours group and one of the 72 hours group being prolonged as long as 72 days after infection.
Further, the findings of 9 human cases treated with immune serum indicate, provided at least some of them were to die developing rabies, that the immune serum treatment initiated not later than 5 days after infection would prevent the onset of rabies. Regarding the superiority of the treatment with immune serum and its combination with vaccine, it can safely be said, on the basis of the findings of Habel1S and Koprowski19, that at least the serum-vaccine combined treatment is superior to the treatment with vaccine alone. While there was no evidence which would support the view to say that the combined treatment is inferior to the treatment with immune serum alone. The findings of our experiments were in the favor to say that the combined treatment was somewhat superior to the treatment with immune serum alone. This may appeare to be quite strange, as it is easily immagined that the simultaneous introduction of the antigen and antibody into the same living body may result in the disappearence of the respective influence.
The best protection was observed, nevertheless, in the group of guinea pigs administered of immune serum and vaccine combinedly. In the guinea pig experiment which was repeated for 2 times, the best protection was observed among the animals given the combined treatment. The animals received the treatment of immune serum alone being the next, the protection of the animals rerceived vaccine treatment alone was the poorest.
Emphasis should be given, however, on the unexpectedly splendid protection, contrary to those unfavorable findings which have hitherto been reported, obtained by vaccination in a Experiment (Table 6) , in which the dose of the street virus infected was extremely small. Out of the 18 guinea pigs each received an intraperitoneal injection of 1 ml of 0.25% ultraviolet irradiation inactivated vaccine which was repeated for 6 times once per every other day (Table 8) , 15 developed rabies and died, however, the isolation of virus on mice from the brain tissue of those animals was not successful in 7 of them and the complement fixation test with the antigen prepared from the same brain material was also negative. Those results may indicate the invasion and the proliferation of rabies virus up to a certain extent which would cause the papalysis of hind legs, but further invasion into the medulla oblongata or the cerebrum was hindered.
On the other hand, the animals in the group received only 1/10 total amount of the vaccine intracutaneously did not show such a remarkable influence of vaccination as observed above. But this difference in the prophylactic effect of vaccination due to the difference in the amount administered between the groups in which the vaccination was done intraperitoneally and that intracutancously was not so much significant in the case of serum-vaccine combined treatment.
The first injection of immune serum must have neutralized a considerable amount of the infected virus at the site of inoculation made 24 hours in advance resulting in an extreme decrease in the amount of infected virus for which the difference in the total amount of vaccine used was of no significance so far as it was beyond a certain limit.
In other words, when vaccine treatment is given together with serum treatment, the intracutaneous inoculation of vaccine in such a small quantity as 1/10 of the peritoneal dose was found to be sufficiently effective.
The findings of our animal experiments, therefore, revealed that the best prophylactic effect was observed in the serum-vaccine combined treatment group. Moreover, the fact that the quantity of vaccine in the combined treatment can be reduced to 1/10 of the quantity which will be required in the treatment with vaccine alone without any appreciable loss in prophylactic effect, may enable to lower the frequency of the occurrence of post-vaccinal paralysis.
As to the fate of immune antibody and antigen or their mutual influences in the animals given serum-vaccine combined treatment, there are yet a number of problems which need further detailed investigations.
Studies are undergoing in our laboratory in an effect to clarify some aspects of the above mentioned problems, and the authors believe that the reports thereof will be made in near future. SUMMARY 1. Immunization of a horse accomplished by the inoculation of ultraviolet inactivated vaccine prepared from the fixed rabies virus MDH strain and that of the living virus of the same strain, yielded an immune serum with such a high neutralizing antibody titer as 1 ml of the serum would neutralize 2,000,000 LD50 of the virus inoculated intracerebrally into mice.
2. Upon commparison of the original immune serum and that purified by the salting with ammonium sulfate, the neutralizing power was found to increase in proportion to the increase in the concentration of y and fi fractions.
3. Hamsters and guinea pigs infected intramuscularly with a varying dose of street virus received the injection of immune serum at a varying period after infection for the comparison of mortality rate. The application of immune serum within 96 hours after infection was confirmed to be still effective.
4. Prophylactic effect of three different treatments immune serum alone, vaccine alone and their combination, was compared on the animals infected with street virus in a dose of 100 LD 50 24 hours in advance. The treatment with vaccine alone, which had not been successful despite the efforts of numerous investigators, was found to lower the morbidity rate. The best protection wass observed in the group received serum vaccine combined treatment. 5. Nine human cases who had received bites from genuine rabid animals were given serum-vaccine combined treatment and the changes in the newtralizing antibody titer of the blood and the spinal fluid were examined. All patients remained normal during the obserrvation period from 300 to 400 days after receiving bite. 
